• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进行性骨化性纤维发育不良患者的灾难性跌倒。

Catastrophic falls in patients who have fibrodysplasia ossificans progressiva.

作者信息

Glaser D L, Rocke D M, Kaplan F S

机构信息

Department of Orthopaedic Surgery, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.

出版信息

Clin Orthop Relat Res. 1998 Jan(346):110-6.

PMID:9577417
Abstract

There have been numerous anecdotal reports of catastrophic falls in patients with fibrodysplasia ossificans progressiva. To determine the incidence of serious morbidity and mortality associated with falls in this patient population, the authors surveyed the 135 patient members of the International Fibrodysplasia Ossificans Progressiva Association and an age and gender matched control group. Eighty-one percent of the fibrodysplasia ossificans progressiva population suffered a fall resulting in injury compared with 44% of the controls. Sixty-seven percent of the falls initiated a painful flareup of fibrodysplasia ossificans progressiva leading to permanent loss of movement in almost all patients. Fifty-four percent of all falls suffered by the fibrodysplasia ossificans progressiva group led to permanent disability compared with 4% of all falls in the control group. Although trauma to the head was a common site of injury in both groups, the injury profile in the fibrodysplasia ossificans progressiva group included traumatic brain injuries, intracranial hemorrhage and death whereas the control group suffered mostly minor soft tissue lacerations. Deficiencies in coordinate gait and protective function likely accounted for the severity of injuries especially to the head in the fibrodysplasia ossificans progressiva population. Precautions are recommended that are intended to minimize the risk of injury without compromising a patient's functional level and independence. These recommendations include limitation of high risk activities, protective head gear, safety improvements in living environments, and augmentation of stabilizing and protective functions.

摘要

有许多关于进行性骨化性纤维发育不良患者灾难性跌倒的轶事报道。为了确定该患者群体中与跌倒相关的严重发病和死亡率,作者对国际进行性骨化性纤维发育不良协会的135名患者成员以及一个年龄和性别匹配的对照组进行了调查。进行性骨化性纤维发育不良患者群体中有81%的人跌倒后受伤,而对照组这一比例为44%。67%的跌倒引发了进行性骨化性纤维发育不良的疼痛发作,几乎所有患者因此导致永久性运动丧失。进行性骨化性纤维发育不良组所有跌倒中有54%导致永久性残疾,而对照组所有跌倒中这一比例为4%。虽然头部创伤在两组中都是常见的受伤部位,但进行性骨化性纤维发育不良组的损伤类型包括创伤性脑损伤、颅内出血和死亡,而对照组大多是轻微的软组织撕裂伤。协调步态和保护功能的缺陷可能是进行性骨化性纤维发育不良患者群体中尤其是头部受伤严重程度的原因。建议采取预防措施,以尽量降低受伤风险,同时不损害患者的功能水平和独立性。这些建议包括限制高风险活动、佩戴防护头盔、改善生活环境安全以及增强稳定和保护功能。

相似文献

1
Catastrophic falls in patients who have fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良患者的灾难性跌倒。
Clin Orthop Relat Res. 1998 Jan(346):110-6.
2
Urinary basic fibroblast growth factor. A biochemical marker for preosseous fibroproliferative lesions in patients with fibrodysplasia ossificans progressiva.尿碱性成纤维细胞生长因子。进行性骨化性纤维发育不良患者骨前纤维增殖性病变的生化标志物。
Clin Orthop Relat Res. 1998 Jan(346):59-65.
3
Human leukocyte antigen B27 allele is not correlated with fibrodysplasia ossificans progressiva.人类白细胞抗原B27等位基因与进行性骨化性纤维发育不良不相关。
Clin Orthop Relat Res. 1998 Jan(346):66-70.
4
Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良中诊断错误导致的医源性损害。
Pediatrics. 2005 Nov;116(5):e654-61. doi: 10.1542/peds.2005-0469. Epub 2005 Oct 17.
5
Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva.成骨不全性纤维发育不良患者的早期死亡率和心肺衰竭。
J Bone Joint Surg Am. 2010 Mar;92(3):686-91. doi: 10.2106/JBJS.I.00705.
6
Effects of intravenous etidronate and oral corticosteroids in fibrodysplasia ossificans progressiva.静脉注射依替膦酸和口服皮质类固醇对进行性骨化性纤维发育不良的影响。
Clin Orthop Relat Res. 1998 Jan(346):117-20.
7
Exoneration of NF-kappaB dysregulation in fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良中NF-κB失调的排除
Clin Orthop Relat Res. 2003 Jan(406):205-13. doi: 10.1097/01.blo.0000030075.92399.11.
8
Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva.成骨形态发生蛋白在进行性骨化性纤维发育不良中的过表达。
N Engl J Med. 1996 Aug 22;335(8):555-61. doi: 10.1056/NEJM199608223350804.
9
Acute lymphocytic infiltration in an extremely early lesion of fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良极早期病变中的急性淋巴细胞浸润。
Clin Orthop Relat Res. 1998 Jan(346):19-25.
10
Influenza-like viral illnesses and flare-ups of fibrodysplasia ossificans progressiva.流感样病毒性疾病和进行性骨化性纤维发育不良的发作
Clin Orthop Relat Res. 2004 Jun(423):275-9. doi: 10.1097/01.blo.0000129557.38803.26.

引用本文的文献

1
Understanding the clinical morbidity and mortality of fibrodysplasia ossificans progressiva: a systematic literature review.进行性骨化性纤维发育不良的临床发病率和死亡率:一项系统文献综述
Orphanet J Rare Dis. 2025 May 31;20(1):262. doi: 10.1186/s13023-025-03763-8.
2
Clinical and radiological insights into fibrodysplasia ossificans progressiva: A report on two cases.进行性骨化性纤维发育不良的临床与影像学见解:两例报告
J Clin Orthop Trauma. 2024 Nov 28;60:102846. doi: 10.1016/j.jcot.2024.102846. eCollection 2025 Jan.
3
Pain Phenotypes in Rare Musculoskeletal and Neuromuscular Diseases.
罕见肌肉骨骼和神经肌肉疾病的疼痛表型。
Neurosci Biobehav Rev. 2021 May;124:267-290. doi: 10.1016/j.neubiorev.2021.02.009. Epub 2021 Feb 10.
4
Heterotopic Ossification: A Comprehensive Review.异位骨化:全面综述
JBMR Plus. 2019 Feb 27;3(4):e10172. doi: 10.1002/jbm4.10172. eCollection 2019 Apr.
5
Identification of the Identical Human Mutation in in 2 Cats With Fibrodysplasia Ossificans Progressiva.在两只患有进行性骨化性纤维发育不良的猫中鉴定出相同的人类突变。
Vet Pathol. 2019 Jul;56(4):614-618. doi: 10.1177/0300985819835585. Epub 2019 Apr 22.
6
A Case of Fibrodysplasia Ossificans Progressiva in a 5-year-old Boy with all Musculoskeletal Features and Review of the Literature.一名5岁男孩的进行性骨化性纤维发育不良病例及所有肌肉骨骼特征并文献复习
J Orthop Case Rep. 2018 Sep-Oct;8(5):36-39. doi: 10.13107/jocr.2250-0685.1200.
7
Bone Resection Osteotomy in Fibrodysplasia Ossificans Progressiva.进行性骨化性纤维发育不良中的骨切除截骨术
J Orthop Case Rep. 2018 Jan-Feb;8(1):39-43. doi: 10.13107/jocr.2250-0685.990.
8
Fibrodysplasia ossificans progressiva: Basic understanding and experimental models.进行性骨化性纤维发育不良:基本认识与实验模型
Intractable Rare Dis Res. 2017 Nov;6(4):242-248. doi: 10.5582/irdr.2017.01055.
9
Granting immunity to FOP and catching heterotopic ossification in the Act.赋予进行性骨化性纤维发育不良豁免权,并在该法案中涵盖异位骨化。
Semin Cell Dev Biol. 2016 Jan;49:30-6. doi: 10.1016/j.semcdb.2015.12.013. Epub 2015 Dec 17.
10
From mysteries to medicines: drug development for fibrodysplasia ossificans progressive.从谜团到药物:进行性骨化性纤维发育不良的药物研发
Expert Opin Orphan Drugs. 2013 Aug;1(8):637-649. doi: 10.1517/21678707.2013.825208.